Eisai Co., Ltd. on 23 announced that it has received a positive opinion from the European Medicines Agency (EMA)'s Commi...
Europital, a globally-focused full-service CRO serving small and mid-tier innovators based in Belgium has recently annou...
The Pathway to Accuracy with Droplet Digital PCR Register tod...
Roquette, a global leader in plant-based ingredients, a pioneer of plant proteins and a world-leading provider of pharma...
TERUMOBCT Unlocking Potential ...
Merck and Pfizer Inc. have recently announced the publication of detailed results from the Phase III JAVELIN Bladder 100...
Eli Lilly and Company and Amgen have announced a global antibody manufacturing collaboration to significantly incre...
Takeda Pharmaceutical Company has announced that it has entered into an agreement to divest its TachoSil® Fibri...
Atomwise, the leader in using artificial intelligence (AI) for small molecule drug discovery based in the US, has announ...
CPhI Annual Report has launched ahead of the first CPhI Festival of Pharma (5-16 October 2020), the world&rsqu...
Eisai Co., Ltd. has established a new pharmaceutical sales subsidiary in Ho Chi Minh City, the Socialist Republic of Vie...
Australia's Department of Health has simplified the way the Pharmaceutical Benefits Scheme (PBS) medicines can be p...
In order to prevent the spread of new psychoactive substances (NPS) and illegal drugs to protect public health, the Ta...
The Therapeutic Goods Administration (TGA) is reminding advertisers that first aid creams containing bufexamac c...
Takeda Pharmaceutical Company Limited in Japan has announced the expansion of its cell therapy manufacturing c...
The COVID-19 pandemic has disrupted the traditional business models of companies. While digital transformation has been ...
Taiwan's Senhwa Biosciences, Inc., a clinical-stage biopharmaceutical company focused on next-generation DNA Damage Re...
The EU-funded project IP Key South-East Asia (SEA) initiates #YourHealthisPriceless on 14 Sep 2020 and launches an onlin...
GELITA AG, the global market leader in the field of gelatine and collagen peptides, appoints Dr. Sven Abend to the Execu...
SK Biopharmaceuticals, Co., Ltd., has announced plans to initiate a Phase 3 clinical trial for cenobamate in A...
AstraZeneca has temporarily put on hold the Phase III study of the University of Oxford COVID-19 vaccine following an un...
China-based Gannex Pharma Co. Ltd., a wholly-owned company of Ascletis Pharma Inc. and Galmed Pharmaceuticals Ltd. ...
Nippon Express Co., Ltd. is in the process of developing pharmaceutical supply chain networks that meet both hardware an...
Japanese firm Takeda Pharmaceutical has announced that it has entered into an agreement to divest a portfolio of se...
Regeneron Pharmaceuticals and Sanofi recently announced new results from a Dupixent® (dupilumab) Phase 3 open-l...
